id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-017428-euzvhtax	Janssens, Wim	Vitamin D and Chronic Obstructive Pulmonary Disease	2012-02-17		.txt	text/plain	8874	249	29	Vitamin D and health: perspectives from mice and man Vitamin D de fi ciency Vitamin D and human health: lessons from vitamin D receptor null mice Gene-environment interactions in chronic obstructive pulmonary disease Chronic obstructive pulmonary disease Projections of global mortality and burden of disease from 2002 to 2030 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespeci fi ed subgroup analysis of a randomised controlled trial Tiotropium as a fi rst maintenance drug in COPD: secondary analysis of the UPLIFT trial Chronic obstructive pulmonary disease: molecular and cellular mechanisms Antielastin autoimmunity in tobacco smoking-induced emphysema Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking Alveolar macrophages as orchestrators of COPD Role of HDAC2 in the pathophysiology of COPD Schematic representation of potential relationship between vitamin D and COPD Defective macrophage phagocytosis of bacteria in COPD Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease COPD exacerbations: de fi ning their cause and prevention Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD New strains of bacteria and exacerbations of chronic obstructive pulmonary disease Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease Susceptibility to exacerbation in chronic obstructive pulmonary disease COPD as a systemic disease Systemic effects of COPD COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention From COPD to chronic systemic in fl ammatory syndrome? Mortality in COPD: role of comorbidities Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism Vitamin D physiology Overview of general physiologic features and functions of vitamin D Identi fi cation and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts Genetics and biology of vitamin D receptor polymorphisms 13th workshop consensus for vitamin D nutritional guidelines Vitamin D de fi ciency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Demographic differences and trends of vitamin D insuf fi ciency in the US population Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Vitamin D toxicity, policy, and science Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act IOM report sets new dietary intake levels for calcium and vitamin D to maintain health and avoid risks associated with excess Relationship between serum 25-hydroxyvitamin d and pulmonary function in the Third National Health and Nutrition Examination Survey Make no bones about it: increasing epidemiologic evidence links vitamin D to pulmonary function and COPD Smoking patterns in African Americans and whites with advanced COPD Common genetic determinants of vitamin D insuf fi ciency: a genome-wide association study Vitamin D binding protein variants and the risk of COPD Candidate genes for COPD in two large data sets Vitamin D de fi ciency, bone mineral density and weight in patients with advanced pulmonary disease Vitamin D de fi ciency is highly prevalent in COPD and correlates with variants in the vitamin D binding gene The vitamin D axis in the lung: a key role for vitamin D-binding protein Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages Relationship of vitamin D status to adult lung function and COPD The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell pro fi le Evaluation of phagocytosis in rickets Control of Mycobacterium tuberculosis through mammalian Toll-like receptors High doses of vitamin D to reduce exacerbations in COPD: a randomized trial A 4-year trial of tiotropium in chronic obstructive pulmonary disease Combined salmeterol and fl uticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial Treatment of COPD: the sooner the better? Decreased histone deacetylase activity in chronic obstructive pulmonary disease VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells DNA methylation-related vitamin D receptor insensitivity in breast cancer Vitamin D and susceptibility of chronic lung diseases: role of epigenetics Peripheral muscle weakness contributes to exercise limitation in COPD Pulmonary rehabilitation in chronic obstructive pulmonary disease Exercise training in COPD: how to distinguish responders from nonresponders Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 Vitamin D status predicts physical performance and its decline in older persons Effect of vitamin D on falls: a metaanalysis Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis Role of vitamin D in skeletal muscle function Osteomalacic myopathy Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial Vitamin D and its role in skeletal muscle Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD Muscle fi ber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease Induction of speci fi c proteins in cultured skeletal muscle cells by 1,25-dihydroxyvitamin D-3 Analysis of the oxidative damage-induced conformational changes of apo-and holocalmodulin by dose-dependent protein oxidative surface mapping The effect of cholecalciferol in vivo on proteins and lipids of skeletal muscle from rachitic chicks Vitamin D and human skeletal muscle	cache/cord-017428-euzvhtax.txt	txt/cord-017428-euzvhtax.txt
